Ascension must sell 7 ASCs to complete $3.9B AmSurg deal: FTC
Alan Condon / beckershospitalreview - St. Louis-based Ascension has received Federal Trade Commission approval to move forward with its planned acquisition of AmSurg — an ambulatory surgery center operator with more than 250 facilities across 34 states — but only after agreeing to divest seve…
AI Summary: The Federal Trade Commission approved Ascension’s $3.9 billion acquisition of AmSurg only after ordering divestitures of specific ambulatory surgery centers to preserve competition. Ascension must sell those ASCs before closing to prevent local market concentration and potential price hikes — because apparently somebody still has to protect patients from monopolies.
Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61
Related Stories
Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128
WakeMed-Atrium merger meets swift North Carolina political pushback / 28 days
Providence explores sale of its health plan amid financial strain / 2 months
Sanford Health to integrate North Memorial with $600M investment / 24 days
Hospital M&A surges in Q1 2026 amid operational strain / 7 wks
MUSC Health buys large South Carolina multispecialty practice for $111M / 2 months
Private equity to acquire Cross Country Healthcare for $437M / 24 days
Justice Department sues NewYork-Presbyterian for antitrust practices / 2 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Cybersecurity, Healthcare Finance, Venture Capital, Food Safety and look for the RSS link.
StackHealth Time Machine